Nna1 mediates purkinje cell dendritic development via lysyl oxidase propeptide and NF-κB signaling

Neuron

Volumn 68, Issue 1, 2010, Pages 45-60

  Li, Jianxue ^a   Gu, Xuesong ^a   Ma, Yinghua ^d   Calicchio, Monica L ^b   Kong, Dong ^a   Teng, Yang D ^a,c   Yu, Lili ^e   Crain, Andrew M ^f   Vartanian, Timothy K ^d   Pasqualini, Renata ^g   Arap, Wadih ^g   Libermann, Towia A ^a   Snyder, Evan Y ^f   Sidman, Richard L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BURNHAM INSTITUTE   (United States)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN LYSINE 6 OXIDASE; PROTEIN NNA1; UNCLASSIFIED DRUG; AGTPBP1 PROTEIN, MOUSE; CARBOXYPEPTIDASE TRANSPEPTIDASE; ENOLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; NERVE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; DENDRITE; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE MUTATION; GENE TRANSFER; GENETIC ANALYSIS; HETEROZYGOSITY; HOMOZYGOSITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROTUBULE; MOLECULAR DYNAMICS; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PURKINJE CELL; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; CELL CULTURE; CEREBELLUM; CYTOLOGY; DISEASE MODEL; DNA MICROARRAY; EXON; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOTOR ACTIVITY; MUTATION; NERVE DEGENERATION; NEWBORN; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; RNA INTERFERENCE; TIME; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELLS, CULTURED; CEREBELLUM; DENDRITES; DISEASE MODELS, ANIMAL; EXONS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN CULTURE TECHNIQUES; PHOSPHOPYRUVATE HYDRATASE; PROTEIN-LYSINE 6-OXIDASE; PSYCHOMOTOR PERFORMANCE; PURKINJE CELLS; RNA INTERFERENCE; SERINE-TYPE D-ALA-D-ALA CARBOXYPEPTIDASE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 77957310202     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2010.08.013     Document Type: Article

References (45)

1. Becker E.B., Oliver P.L., Glitsch M.D., Banks G.T., Achilli F., Hardy A., Nolan P.M., Fisher E.M., Davies K.E. A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice. Proc. Natl. Acad. Sci. USA 2009, 106:6706-6711.
2. Bedard K., Szabo E., Michalak M., Opas M. Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int. Rev. Cytol. 2005, 245:91-121.
3. Buchinger B., Spitzer S., Karlic H., Klaushofer K., Varga F. Lysyl oxidase (LOX) mRNA expression and genes of the differentiated osteoblastic phenotype are upregulated in human osteosarcoma cells by suramin. Cancer Lett. 2008, 265:45-54.
4. Chauhan N., Siegel G. Age-dependent organotypic expression of microtubule-associated proteins (MAP1, MAP2, and MAP5) in rat brain. Neurochem. Res. 1997, 22:713-719.
5. Dusart I., Guenet J.L., Sotelo C. Purkinje cell death: differences between developmental cell death and neurodegenerative death in mutant mice. Cerebellum 2006, 5:163-173.
6. Erler J.T., Bennewith K.L., Nicolau M., Dornhöfer N., Kong C., Le Q.T., Chi J.T., Jeffrey S.S., Giaccia A.J. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 2006, 440:1222-1226.
7. Ford G.D., Ford B.D., Steele E.C., Gates A., Hood D., Matthews M.A.B., Mirza S., MacLeish P.R. Analysis of transcriptional profiles and functional clustering of global cerebellar gene expression in PCD3J mice. Biochem. Biophys. Res. Commun. 2008, 377:556-561.
8. Gilad G.M., Kagan H.M., Gilad V.H. Lysyl oxidase, the extracellular matrix-forming enzyme, in rat brain injury sites. Neurosci. Lett. 2001, 310:45-48.
9. Gilad G.M., Kagan H.M., Gilad V.H. Evidence for increased lysyl oxidase, the extracellular matrix-forming enzyme, in Alzheimer's disease brain. Neurosci. Lett. 2005, 376:210-214.
10. Greene L.A., Liu D.X., Troy C.M., Biswas S.C. Cell cycle molecules define a pathway required for neuron death in development and disease. Biochim. Biophys. Acta 2007, 1772:392-401.
11. Guo Y., Pischon N., Palamakumbura A.H., Trackman P.C. Intracellular distribution of the lysyl oxidase propeptide in osteoblastic cells. Am. J. Physiol. Cell Physiol. 2007, 292:C2095-C2102.
12. Gutierrez H., Hale V.A., Dolcet X., Davies A. NF-kappaB signaling regulates the growth of neural processes in the developing PNS and CNS. Development 2005, 132:1713-1726.
13. Hirai H. Progress in transduction of cerebellar Purkinje cells in vivo using viral vectors. Cerebellum 2008, 7:273-278.
14. Hurtado P.A., Vora S., Sume S.S., Yang D., St Hilaire C., Guo Y., Palamakumbura A.H., Schreiber B.M., Ravid K., Trackman P.C. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem. Biophys. Res. Commun. 2008, 366:156-161.
15. Kapfhammer J.P. Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog. Histochem. Cytochem. 2004, 39:131-182.
16. Kyuhou S., Kato N., Gemba H. Emergence of endoplasmic reticulum stress and activated microglia in Purkinje cell degeneration mice. Neurosci. Lett. 2006, 396:91-96.
17. Landis S.C., Mullen R.J. The development and degeneration of Purkinje cells in pcd mutant mice. J. Comp. Neurol. 1978, 177:125-143.
18. Li P.A., He Q., Cao T., Yong G., Szauter K.M., Fong K.S., Karlsson J., Keep M.F., Csiszar K. Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 2004, 120:115-122.
19. Li J., Imitola J., Snyder E.Y., Sidman R.L. Neural stem cells rescue nervous Purkinje neurons by restoring molecular homeostasis of tissue plasminogen activator and downstream targets. J. Neurosci. 2006, 26:7839-7848.
20. Li J., Ma Y., Teng Y.D., Zheng K., Vartanian T.K., Snyder E.Y., Sidman R.L. Purkinje neuron degeneration in nervous (nr) mutant mice is mediated by a metabolic pathway involving excess tissue plasminogen activator. Proc. Natl. Acad. Sci. USA 2006, 103:7847-7852.
21. Lucero H.A., Kagan H.M. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell. Mol. Life Sci. 2006, 63:2304-2316.
22. Mäki J.M. Lysyl oxidases in mammalian development and certain pathological conditions. Histol. Histopathol. 2009, 24:651-660.
23. Meffert M.K., Chang J.M., Wiltgen B.J., Fanselow M.S., Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat. Neurosci. 2003, 6:1072-1078.
24. Min C., Kirsch K.H., Zhao Y., Jeay S., Palamakumbura A.H., Trackman P.C., Sonenshein G.E. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res. 2007, 67:1105-1112.
25. Mullen R.J. Site of pcd gene action and Purkinje cell mosaicism in cerebella of chimaeric mice. Nature 1977, 270:245-247.
26. Palamakumbura A.H., Jeay S., Guo Y., Pischon N., Sommer P., Sonenshein G.E., Trackman P.C. The propeptide domain of lysyl oxidase induces phenotypic reversion of Ras-transformed cells. J. Biol. Chem. 2004, 279:40593-40600.
27. Palamakumbura A.H., Vora S.R., Nugent M.A., Kirsch K.H., Sonenshein G.E., Trackman P.C. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 2009, 28:3390-3400.
28. Payne S.L., Hendrix M.J., Kirschmann D.A. Paradoxical roles for lysyl oxidases in cancer - a prospect. J. Cell. Biochem. 2007, 101:1338-1354.
29. Poulain F.E., Chauvin S., Wehrlé R., Desclaux M., Mallet J., Vodjdani G., Dusart I., Sobel A. SCLIP is crucial for the formation and development of the Purkinje cell dendritic arbor. J. Neurosci. 2008, 28:7387-7398.
30. Rodríguez C., Martínez-González J., Raposo B., Alcudia J.F., Guadall A., Badimon L. Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases. Cardiovasc. Res. 2008, 79:7-13.
31. Rossi F., Tempia F. Unraveling the Purkinje neuron. Cerebellum 2006, 5:75-76.
32. Royuela M., Rodríguez-Berriguete G., Fraile B., Paniagua R. TNF-alpha/IL-1/NF-kappaB transduction pathway in human cancer prostate. Histol. Histopathol. 2008, 23:1279-1290.
33. Sarna J.R., Hawkes R. Patterned Purkinje cell death in the cerebellum. Prog. Neurobiol. 2003, 70:473-507.
34. Sawada Y., Kajiwara G., Iizuka A., Takayama K., Shuvaev A.N., Koyama C., Hirai H. High transgene expression by lentiviral vectors causes maldevelopment of Purkinje cells in vivo. Cerebellum 2010, in press. Published online February 23, 2010. 10.1007/s12311-010-0161-1.
35. Shima Y., Kengaku M., Hirano T., Takeichi M., Uemura T. Regulation of dendritic maintenance and growth by a mammalian 7-pass transmembrane cadherin. Dev. Cell 2004, 7:205-216.
36. Sirzen-Zelenskaya A., Zeyse J., Kapfhammer J.P. Activation of class I metabotropic glutamate receptors limits dendritic growth of Purkinje cells in organotypic slice cultures. Eur. J. Neurosci. 2006, 24:2978-2986.
37. Sotelo C., Dusart I. Intrinsic versus extrinsic determinants during the development of Purkinje cell dendrites. Neuroscience 2009, 162:589-600.
38. Szauter K.M., Cao T., Boyd C.D., Csiszar K. Lysyl oxidase in development, aging and pathologies of the skin. Pathol. Biol. (Paris) 2005, 53:448-456.
39. Tabata T., Sawada S., Araki K., Bono Y., Furuya S., Kano M. A reliable method for culture of dissociated mouse cerebellar cells enriched for Purkinje neurons. J. Neurosci. Methods 2000, 104:45-53.
40. Takayama K., Torashima T., Horiuchi H., Hirai H. Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci. Lett. 2008, 443:7-11.
41. Teng J., Takei Y., Harada A., Nakata T., Chen J., Hirokawa N. Synergistic effects of MAP2 and MAP1B knockout in neuronal migration, dendritic outgrowth, and microtubule organization. J. Cell Biol. 2001, 155:65-76.
42. Torashima T., Yamada N., Itoh M., Yamamoto A., Hirai H. Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia. Eur. J. Neurosci. 2006, 24:371-380.
43. Wang T., Morgan J.I. The Purkinje cell degeneration (pcd) mouse: an unexpected molecular link between neuronal degeneration and regeneration. Brain Res. 2007, 1140:26-40.
44. Wong R.O., Ghosh A. Activity-dependent regulation of dendritic growth and patterning. Nat. Rev. Neurosci. 2002, 3:803-812.
45. Wu M., Min C., Wang X., Yu Z., Kirsch K.H., Trackman P.C., Sonenshein G.E. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells. Cancer Res. 2007, 67:6278-6285.